Columns - Pharmaceutical Executive

ADVERTISEMENT

Columns

Meetings: Doctor Consultation

April 1, 2006

Meetings at which peripheral activities become the focal point are likely to attract scrutiny.

Backpage: Warning Letter

March 1, 2006

This letter concerns the FDA press release dated January 18, 2006, entitled "FDA Announces New Prescription Drug Information Format to Improve Patient Safety." The information contained is considered false and misleading, and lacking in fair balance.

From the Editor: Fine Whines

March 1, 2006

The newspapers seem shocked to learn that scientific journals occasionally publish things that aren't true. Where have they been?

Finance: Promotional Productivity

March 1, 2006

Lovenox still needs a defense strategy to hold share, but it requires less investment as a specialty product. Instead, Lovenox should throw cash over to Acomplia, the putative future star of the Sanofi-Aventis portfolio.

Legal: Hey, Good Lookin': Sex Discrimination in Hiring Reps

March 1, 2006

Drug manufacturers should have policies against sexual harassment of sales reps. Such a policy may also help counter charges that a company is implicitly encouraging its reps to use their sexuality as a sales tool.

Global Report: Chemicals Legislation in Europe

March 1, 2006

Drugs are not directly addressed in Europe's new legislation for chemicals. But they'll be affected, because chemicals are used in drug manufacturing.

Direct to Consumer: Q&A with Jill Balderson

March 1, 2006

We need to do more than just distribute information—we need to look at how consumers process, internalize, and act on that information. Health education is a process that is very personal and complex.

Marketing to Professionals: Under the Influence

March 1, 2006

Marketers should target doctors who exhibit a high level of influence and connectivity among prescribers within and outside their specialities. Often, doctors' influence can extend to general practitioners, too.

Thought Leader: Q&A with Hugo Stephenson

March 1, 2006

Companies don't have the budget, but are being forced to do more active surveillance.

ADVERTISEMENT

Click here